# X-ray Dose Reduction Study for Endovascular Interventional Radiology

> **NCT01599741** · NA · COMPLETED · sponsor: **Philips Clinical & Medical Affairs Global** · enrollment: 51 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **RADIATION:** Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.
- **RADIATION:** Normal dose DSA with conventional X-ray imaging technology

## Key facts

- **NCT ID:** NCT01599741
- **Lead sponsor:** Philips Clinical & Medical Affairs Global
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01599741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01599741, "X-ray Dose Reduction Study for Endovascular Interventional Radiology". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01599741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*